AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] Iovance Biotherapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Iovance Biotherp

NASDAQ:IOVA

IOVA Rankings

IOVA Latest News

IOVA Latest SEC Filings

IOVA Stock Data

875.69M
331.64M
0.35%
69.38%
19.8%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SAN CARLOS